Acute Myeloid Leukaemia (AML)
Oncology·MeSH: Leukemia, Myeloid, Acute
Prevalence
30.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2/Phase 3(1)
Frequently asked questions
How many drugs are in development for Acute Myeloid Leukaemia (AML)?
BioSniper tracks 1 drug in development for Acute Myeloid Leukaemia (AML) across 1 company.
How many clinical trials target Acute Myeloid Leukaemia (AML)?
There are 1 clinical trial targeting Acute Myeloid Leukaemia (AML) tracked by BioSniper.
What is the prevalence of Acute Myeloid Leukaemia (AML)?
The estimated prevalence of Acute Myeloid Leukaemia (AML) is approximately 30.0 per 100,000 population.
Deep-dive into Acute Myeloid Leukaemia (AML)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis